Novel Transcriptional & Post-Transcriptional Regulators of Endothelial Metabolism in Atherosclerosis
小说转录
基本信息
- 批准号:10389265
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATP binding cassette transporter 1AddressAffectAgonistAnti-Inflammatory AgentsAntiatherogenicAtherosclerosisAttenuatedBehaviorBindingBiogenesisCardiovascular DiseasesCell physiologyCellsCellular Metabolic ProcessCholesterolDataElementsEndothelial CellsEndotheliumEnzymesExcisionFunctional disorderGene ExpressionGenerationsGenesGeneticGenetic TranscriptionGoalsHepaticHigh Density LipoproteinsHomeostasisHypoxiaInflammationInflammatoryInflammatory ResponseLabelLigandsLinkLipidsLiteratureLiver X ReceptorMaintenanceMapsMesenchymalMessenger RNAMetabolicMetabolic PathwayMetabolismMicroRNAsMissionMolecularMusNitric OxideNuclear ReceptorsOxidation-ReductionPathway interactionsPermeabilityPhenotypePhysiologicalPost-Transcriptional RegulationProcessProteinsProteomicsPublic HealthReceptor SignalingRegulationResearchRoleSchemeSignal TransductionSterolsStimulusTestingTranscriptional RegulationUnited States National Institutes of HealthUntranslated RNAVascular Diseasesatherogenesisatheroprotectivebasecell typecytokineexperimental studyfatty acid oxidationgene networkgenomic datain vitro testinginsightlipid metabolismloss of functionmacrophagemetabolic phenotypemetabolomicsmouse modelneglectnoveloxidationpreventresponseshear stresstherapeutic targettranscription factortranscriptome sequencingtranscriptomicsvascular inflammation
项目摘要
PROJECT SUMMARY
The progression of cardiovascular disease has only recently been noted to involve changes in endothelial (EC)
metabolism. Atherosclerosis, a disease of vascular lipid accumulation and inflammation, is linked to a
metabolic switch of the endothelium. However, the regulation of this switch is incompletely defined. Small non-
coding microRNAs have recently been identified as regulators of inflammation and metabolism. For example,
microRNA-33 (miR-33) has been extensively implicated in lipid metabolism, yet its precise role in ECs is
unknown. Another master regulator of lipid metabolism, whose role in ECs is yet to be defined, is Liver X
Receptor (LXR). This proposal seeks to determine how endothelial-specific miR-33 and LXR regulate EC
metabolism and determine if their disruption affects atherosclerotic progression. miR-33 attenuates the
removal of cholesterol from cells while on the other hand LXR signaling promotes this process. Since
cholesterol retention is implicated in atherogenic processes in the endothelium, this suggests a pro-
atherogenic role for endothelial miR-33 and an anti-atherogenic role for endothelial LXR signaling. Additionally,
other miR-33 targets include enzymes in fatty acid oxidation (FAO). Since dampened FAO promotes
atherogenic EC processes such as the Endothelial to Mesenchymal Transition, this emphasizes another pro-
atherogenic role of miR-33. Notably, there are several points of possible crosstalk between miR-33 and LXR
signaling – namely that LXR can potentially regulate miR-33 expression and that the miR-33 targets include
LXR-induced genes – suggesting an interplay between their effects on metabolism. Therefore, the central
hypothesis is that miR-33 and LXRs operate in complementary fashions to maintain cholesterol and lipid
homeostasis in ECs, and that disruption of either of their signaling perpetuates atherosclerosis. This
hypothesis will be tested by addressing the following specific aims: 1) Investigate the role of miR-33 in
modulating EC lipid metabolism and atherosclerosis; 2) Delineate the contribution of LXR signaling to EC
metabolism and dysfunction in atherosclerosis. The use of novel mouse models with endothelial-specific
deletion of miR-33 or the LXRs will provide key insight into their role in atherogenesis. These aims will then be
further tested in vitro with a combination of state-of-the-art approaches upon miR-33 or LXR gain- or loss-of-
function to determine their regulation of EC metabolism. The proposed research is significant because it is
expected to identify two critical cell-autonomous regulators of endothelial metabolism and atherosclerosis.
Long-term, the goal of this project is to deepen our understanding of the regulation of EC metabolism and
identify novel regulators that can be therapeutically targeted in cardiovascular disease.
项目摘要
心血管疾病的进展只是最近才注意到涉及内皮细胞(EC)的变化,
新陈代谢.动脉粥样硬化是一种血管脂质积聚和炎症的疾病,
内皮的代谢开关。然而,该开关的调节不完全定义。小非-
编码microRNA最近被鉴定为炎症和代谢的调节剂。比如说,
microRNA-33(miR-33)广泛参与脂质代谢,但其在EC中的确切作用尚不清楚。
未知另一个脂质代谢的主要调节剂是肝脏X,其在EC中的作用尚未确定
受体(LXR)。该提案旨在确定内皮特异性miR-33和LXR如何调节EC
代谢,并确定它们的破坏是否影响动脉粥样硬化的进展。miR-33减弱了
从细胞中去除胆固醇,而另一方面LXR信号传导促进这一过程。以来
胆固醇潴留与内皮的致动脉粥样硬化过程有关,这表明
内皮miR-33的致动脉粥样硬化作用和内皮LXR信号传导的抗动脉粥样硬化作用。此外,本发明的目的是,
其它miR-33靶包括脂肪酸氧化(FAO)中的酶。由于粮农组织促进
致动脉粥样硬化EC过程,如内皮细胞间质转化,这强调了另一个促
miR-33的致动脉粥样硬化作用。值得注意的是,在miR-33和LXR之间存在几个可能的串扰点。
信号传导-即LXR可以潜在地调节miR-33表达,并且miR-33靶点包括
LXR诱导的基因-表明它们对代谢的影响之间存在相互作用。因此中央
一种假说是miR-33和LXR以互补方式运作,以维持胆固醇和脂质
内皮细胞内稳态和它们信号传导中的任一个的破坏使动脉粥样硬化永久化。这
将通过解决以下具体目标来检验假设:1)研究miR-33在以下方面的作用
2)阐明LXR信号通路对EC脂质代谢和动脉粥样硬化的作用
动脉粥样硬化的代谢和功能障碍。使用具有内皮特异性的新型小鼠模型
miR-33或LXR的缺失将提供对它们在动脉粥样硬化形成中的作用的关键了解。这些目标将是
进一步在体外测试了miR-33或LXR获得或丧失的最新方法的组合,
功能,以确定其调节EC代谢。这项研究之所以重要,是因为
有望确定内皮代谢和动脉粥样硬化的两个关键细胞自主调节剂。
从长远来看,本项目的目标是加深我们对EC代谢调节的理解,
鉴定可以在心血管疾病中治疗靶向的新型调节剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn Citrin其他文献
Kathryn Citrin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn Citrin', 18)}}的其他基金
Novel Transcriptional & Post-Transcriptional Regulators of Endothelial Metabolism in Atherosclerosis
小说转录
- 批准号:
10683705 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant